US Broker Ratings

Veracyte, Inc. (VCYT) Stock Analysis: Uncovering a Promising 34.96% Upside for Investors

Veracyte, Inc. (VCYT), a prominent player in the healthcare sector, specifically within the diagnostics and research industry, stands as a compelling prospect for investors seeking exposure..

Kymera Therapeutics (KYMR) Stock Analysis: Exploring a 30% Upside Potential Amid Biotech Innovation

Kymera Therapeutics, Inc. (NASDAQ: KYMR) is a name that has been gaining traction in the biotechnology sector, particularly for its innovative approach to drug development. As..

Liquidia Corporation (LQDA) Investor Outlook: Unveiling a 38.98% Potential Upside in the Biopharma Sphere

For investors with an eye on the biopharmaceutical sector, Liquidia Corporation (NASDAQ: LQDA) presents an intriguing opportunity. Operating within the niche of drug manufacturing, specializing in..

Dyne Therapeutics, Inc. (DYN) Stock Analysis: A Potential 142% Upside in the Biotech Arena

Dyne Therapeutics, Inc. (NASDAQ: DYN), a clinical-stage biotechnology company focused on neuromuscular diseases, has sparked investor interest with its promising pipeline and potential for substantial stock..

Innoviva, Inc. (INVA) Stock Analysis: With a 45% Potential Upside, Is It Time to Buy?

Innoviva, Inc. (NASDAQ: INVA) is making waves in the biotechnology sector with its compelling growth metrics, strategic partnerships, and a significant potential upside that individual investors..

Aveanna Healthcare Holdings Inc (AVAH): Analyst Ratings Reveal 48% Potential Upside

Aveanna Healthcare Holdings Inc. (NASDAQ: AVAH), a prominent player in the U.S. medical care facilities industry, has garnered significant attention from investors due to its impressive..

Mineralys Therapeutics, Inc. (MLYS) Stock Analysis: Exploring a Promising 73.52% Potential Upside for Investors

Mineralys Therapeutics, Inc. (NASDAQ: MLYS) is gaining traction among investors in the healthcare sector, particularly those focused on biotechnology. With a market capitalization of $2.32 billion,..

Merus N.V. (MRUS) Stock Analysis: A Look at Its 7.78% Potential Upside in the Biotech Arena

Merus N.V. (NASDAQ: MRUS), a prominent player in the biotechnology sector, is capturing investor attention with its innovative approach to antibody therapeutics. Headquartered in the Netherlands,..

Integra LifeSciences Holdings C (IART) Stock Analysis: Evaluating a 45% Upside Potential Amidst Market Challenges

Integra LifeSciences Holdings Corporation (NASDAQ: IART) remains a notable player in the healthcare sector, specifically within the medical devices industry. Headquartered in Princeton, New Jersey, Integra..

Pacira BioSciences, Inc. (PCRX) Stock Analysis: A Potential 36% Upside for Investors in Pain Management Solutions

Investors focusing on the healthcare sector may find Pacira BioSciences, Inc. (NASDAQ: PCRX) a compelling option, particularly given the company’s strong foothold in non-opioid pain management..

Disc Medicine, Inc. (IRON) Stock Analysis: A 50% Potential Upside in the Biotech Sector

Disc Medicine, Inc. (NASDAQ: IRON) stands out in the healthcare sector with a promising outlook in the biotechnology industry. Despite its current trading price of $66.54,..

Ocular Therapeutix, Inc. (OCUL) Stock Analysis: 136% Potential Upside Captivates Investor Interest

Ocular Therapeutix, Inc. (NASDAQ: OCUL), a prominent player in the biotechnology sector, is capturing the attention of investors with its promising portfolio and remarkable potential upside...

Amneal Pharmaceuticals, Inc. (AMRX) Stock Analysis: Exploring a 19% Upside Potential

Investors looking for growth opportunities in the healthcare sector may find Amneal Pharmaceuticals, Inc. (NYSE: AMRX) an intriguing candidate. This global biopharmaceutical company, with a market..

Zai Lab Limited (ZLAB) Stock Analysis: Exploring a 113.65% Upside Potential

Zai Lab Limited (NASDAQ: ZLAB), a leading biopharmaceutical company based in China, stands at a pivotal moment in its journey. With an impressive market cap of..

PROCEPT BioRobotics Corporation (PRCT) Investor Outlook: Unveiling the 23.55% Potential Upside in Healthcare Robotics

PROCEPT BioRobotics Corporation (NASDAQ: PRCT) is steadily carving its niche in the healthcare sector, specifically within the medical devices industry. Headquartered in San Jose, California, the..

Aurinia Pharmaceuticals Inc (AUPH): Investor Outlook Reveals 19.63% Potential Upside

Aurinia Pharmaceuticals Inc (NASDAQ: AUPH), a key player in the biotechnology sector, is capturing investor interest with its promising potential upside of 19.63%. Headquartered in Edmonton,..

Guardian Pharmacy Services, Inc (GRDN): A Strong Buy with Promising Growth Potential in the Healthcare Sector

Guardian Pharmacy Services, Inc. (NASDAQ: GRDN), a key player in the healthcare sector, operates within the medical care facilities industry, focusing on long-term health care facilities..

Kestra Medical Technologies (KMTS) Stock Analysis: Exploring 27% Potential Upside in Healthcare Innovation

Kestra Medical Technologies, Ltd. (NASDAQ: KMTS) is making waves in the healthcare sector, particularly within the medical instruments and supplies industry. Founded in 2014 and headquartered..

U.S. Physical Therapy, Inc. (USPH) Stock Analysis: A 26.86% Potential Upside in the Healthcare Sector

U.S. Physical Therapy, Inc. (NYSE: USPH) has been garnering attention among investors, particularly those with an interest in the healthcare sector. With a market capitalization of..

AdaptHealth Corp. (AHCO) Stock Analysis: Exploring a 33.56% Potential Upside in the Medical Devices Sector

AdaptHealth Corp. (NASDAQ: AHCO) stands as a significant player in the U.S. healthcare landscape, operating within the medical devices industry. Despite facing certain operational challenges, the..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds